Elevance Health (ELV) Revenue — Quarter Ended Jun 30, 2024
Revenue for the quarter increased compared to both the immediately preceding quarter and the same quarter one year earlier. The growth rate versus the prior year was modest, while the sequential improvement was more pronounced.
Key takeaway
Quarter ended Jun 30, 2024 · FY2024 Q2
Revenue for the quarter increased compared to both the immediately preceding quarter and the same quarter one year earlier. The growth rate versus the prior year was modest, while the sequential improvement was more pronounced.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$43.9B
Revenue reported for this quarter.
Quarter-over-quarter
+3.1%
Change from the immediately preceding quarter.
Year-over-year
+0.5%
Change from the comparable year-ago quarter.
Trailing four quarters
$172B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2023 | $42.8B | +7.3% |
| Dec 31, 2023 | $42.6B | +6.8% |
| Mar 31, 2024 | $42.6B | +1.0% |
| Jun 30, 2024 | $43.9B | +0.5% |
Revenue performance
Reported revenue rose from the prior quarter, reflecting a sequential acceleration. On a year-over-year basis, revenue also increased, though at a slower pace than in earlier periods.
Quarterly comparison
Compared with the preceding quarter, revenue grew at a higher rate. Versus the same quarter a year ago, the increase was smaller, indicating a deceleration in annual growth.
What to watch
The year-over-year revenue growth rate has continued to decelerate, which may warrant monitoring in future quarters.